Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
about
Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.Signalling pathways implicated in early mammary gland morphogenesis and breast cancer.TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic ProcessAnalysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb developmentProteomics of TGF-beta signaling and its impact on breast cancer.Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system.Genome-wide association analysis identifies three new breast cancer susceptibility loci.The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancerTBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesisThe oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathwayomb and circumstance.The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypesThe expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines.Tbx3 overexpression in human gastric cancer is correlated with advanced tumor stage and nodal status and promotes cancer cell growth and invasion.PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.The retinoblastoma protein modulates Tbx2 functional specificity.UV-mediated regulation of the anti-senescence factor Tbx2.Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer.Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.Diverse functional networks of Tbx3 in development and diseaseA meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.
P2860
Q31115547-8EBD8547-21CD-4E09-923D-34CD54FF61BBQ33255332-FBDC64DF-AB9C-4582-AE9B-004A750B1FD8Q34062681-D133B555-8065-4D39-993B-A566B0A0822AQ34452650-4EE81915-C5D6-4649-8765-BE69AFBF8922Q34738135-F52BCF6E-8D1C-4EE8-9E3C-1F608FD2EAD4Q34972267-734D4B21-CD9D-41E5-A312-F1E93CA1AACBQ35937737-F1FCDD09-F189-4158-9A5E-2D06C9AEB01BQ36030510-34A174ED-815C-40E6-8179-E632757A52DFQ36322164-61DF8AE4-9B8E-49C5-9AA1-DE6460A208BBQ36415747-DBC10D10-23B1-427B-984C-72072FA56DEDQ36842233-2BD1A101-BFFF-47B7-9045-93F214487FA7Q36955132-D5A7B9EA-55AA-421E-A9C1-FA497AF621C4Q37026584-58FFE801-A52D-4780-AD78-CDE3EB1F874AQ37065772-87FE807F-D3C8-411D-ACCD-2B53B0DAAB41Q37306208-6021BF95-1E67-4493-908B-4ABE2D3419BDQ37340390-452F4E06-6D9C-4D11-965B-4DC548B96DDCQ37499273-5292B24A-8474-4C4B-94F5-AD6EA5C8BD2BQ38543511-36AD5A61-04C2-4644-8C5B-BD2469350281Q38736567-28BDF769-8BC0-4411-B59E-DBF3754850BEQ39644953-1AAF695C-E7A2-45E8-B9FA-C7C52AE7BE22Q39695180-38602877-50E3-44AA-B860-63B4BD5D645DQ40048508-EE9C9D40-538F-43CD-ADFA-7960A5A48A3FQ41040816-E5C124BD-DFF8-44DB-9A59-657F5D5B94AAQ41860885-333C02D0-457C-44DC-B442-98B0DB071DE5Q42075975-6B79B040-11EB-4BA0-9032-5E2688750C9AQ44792025-3A3840C1-4823-4644-BEAE-CF4E96DD82E3
P2860
Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Increased expression of cSHMT, ...... ian and breast cancer patients
@ast
Increased expression of cSHMT, ...... ian and breast cancer patients
@en
Increased expression of cSHMT, ...... ian and breast cancer patients
@nl
type
label
Increased expression of cSHMT, ...... ian and breast cancer patients
@ast
Increased expression of cSHMT, ...... ian and breast cancer patients
@en
Increased expression of cSHMT, ...... ian and breast cancer patients
@nl
prefLabel
Increased expression of cSHMT, ...... ian and breast cancer patients
@ast
Increased expression of cSHMT, ...... ian and breast cancer patients
@en
Increased expression of cSHMT, ...... ian and breast cancer patients
@nl
P2093
P356
P1476
Increased expression of cSHMT, ...... ian and breast cancer patients
@en
P2093
Marta Lomnytska
Natalya Volodko
Serhiy Souchelnytskyi
Ulf Hellman
P2860
P304
P356
10.1002/IJC.21332
P407
P577
2006-01-01T00:00:00Z